Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Markers Could Predict Risk of Severe Chlamydia Infection

By LabMedica International staff writers
Posted on 15 Aug 2025

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract. More...

Currently, ascension into the uterus and endometrium can only be confirmed through an invasive endometrial biopsy. Researchers have now identified biological markers that may pave the way for new diagnostics to predict a woman’s risk of severe infection without the need for such procedures.

A collaborative team from North Carolina State University (Raleigh, NC, USA) and the UNC School of Medicine (Chapel Hill, NC, USA) analyzed cervicovaginal microbiome (CVM) samples from 246 women in a high-risk cohort for chlamydia. Using 16S ribosomal RNA (rRNA) gene-based high-throughput amplicon sequencing, they tagged and quantified bacteria present in the samples. Participants were classified into three groups—CT negative, CT positive, and CT ascended—to assess differences in microbiome composition.

The sequencing analysis revealed that higher amounts of certain bacterial species, such as Hemophilus haemolyticus, Sutterella stercoricanis, and Actinobaculum massiliense, were predictive of ascended infections. These microbes also correlated with seven cytokines previously linked to chlamydia spread. Notably, the study found that the bacterial load of chlamydia itself was the strongest predictor of ascension.

The findings, published in Infection and Immunity, indicate that specific microbial and immune profiles could be developed into biomarkers to identify women at high risk for upper genital tract infection. Such diagnostics could enable earlier intervention, potentially preventing severe reproductive outcomes. Future studies will focus on understanding how these microbes influence immune responses to control chlamydia levels and disease progression.

"We knew that some bacterial species make a woman more susceptible to CT infection, while ‘good’ bacteria such as lactobacillus seem to make it harder to become infected," said Catherine O’Connell, professor of pediatrics, UNC School of Medicine, and co-project leader. “This work shows that other bacteria present may be keeping host immunity alert and responsive, making it harder for infecting chlamydia to grow abundantly. It shows that there is potential for developing biomarkers to identify women at high risk for ascended CT.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.